Vanda Pharmaceuticals (VNDA) Change in Account Payables (2010 - 2015)

Vanda Pharmaceuticals has disclosed Change in Account Payables across 6 years of filings, most recently posting $142000.0 for Q2 2015.

• Change in Account Payables for Q2 2015 came in at $142000.0, up 120.14% year-over-year; the trailing twelve-month figure through Jun 2015 was $1.4 million (up 250.49% YoY), and the FY2014 annual result was $174000.0, down 53.48% from the prior year.
• Change in Account Payables came in at $142000.0 for Q2 2015 at Vanda Pharmaceuticals, down from $654000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $909000.0 in Q2 2012 to a low of -$803000.0 in Q4 2012.
• The 5-year median for Change in Account Payables is $164000.0 (2011), against an average of $54611.1.
• Across the five-year window, Change in Account Payables tumbled 14875.0% in 2012 and jumped 482.41% in 2013, its largest moves.
• Vanda Pharmaceuticals' Change in Account Payables stood at -$337000.0 in 2011, then plunged by 138.28% to -$803000.0 in 2012, then soared by 136.36% to $292000.0 in 2013, then declined by 1.37% to $288000.0 in 2014, then sank by 50.69% to $142000.0 in 2015.
• The last three Change in Account Payables figures came in at $142000.0 (Q2 2015), $654000.0 (Q1 2015), and $288000.0 (Q4 2014), per Business Quant data.